Last week, the FTC alleged that a private equity firm undertook a “multi-year anticompetitive scheme” to dominate Texas anesthesiology practices through: (1) “serial” acquisitions...
Last week, the FTC settled a director interlock lawsuit with EQT/Quantum, which is notable for three key reasons: (1) it confirms the FTC’s focus on enforcing the interlocking directora...
Proposed changes to the HSR Form and Instructions would, if adopted, substantially increase the time and cost of compliance for private equity firms. The proposed rules would require mor...
On July 19, 2023, the DOJ and FTC released a draft overhaul of the merger guidelines (the Draft Guidelines). Some portions of the Draft Guidelines are consistent with agency practice fro...
On July 10, 2023, Judge Jacqueline Scott Corley of the U.S. District Court for the Northern District of California denied the FTC’s motion for a preliminary injunction to block Microsof...
The U.S. antitrust authorities have proposed extensive changes to the Hart-Scott-Rodino filing requirements. If implemented, these changes will obligate filing parties to provide substant...
In its second enforcement action under the Health Breach Notification Rule, the Federal Trade Commission (FTC) reinforces the administration’s focus on protecting reproductive health da...
On April 14, a unanimous Supreme Court held that parties can challenge the constitutionality of the FTC’s and SEC’s administrative proceedings in federal court before an agency review...
In 2022, China amended its Anti-Monopoly Law (AML) for the first time in fourteen years. This “New AML” significantly increases penalties for antitrust violations, provides greater f...
In its first enforcement action under the Health Breach Notification Rule, the Federal Trade Commission (FTC) underscores its focus on sensitive health information and imposes a permanent...
